Rare diseases
Investigational molecules
Locations
221 Crescent Street Suite 103a, 02453-3425, United States
Viridian Therapeutics Inc. concentrates its clinical research on thyroid eye disease and thyroid eye disease (TED), with studies spanning both active and chronic forms of the condition. The sponsor’s portfolio centers on therapies intended to address the signs and symptoms associated with orbital inflammation and related eye involvement.
Its research activity reflects sustained interest in treatment options for patients across different stages of TED.
Viridian Therapeutics Inc. runs clinical trials in conditions such as Endocrine ophthalmopathy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Germany
FranceFranceFranceGermany
CzechiaFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
